Journal profile · Dentistry-Dentistry (miscellaneous)
Journal of Molecular and Cellular Cardiology Plus
ISSN 2772-9761 · Elsevier · United Kingdom
Journal of Molecular and Cellular Cardiology Plus: CAS Zone 4 · Medicine (2026 Xinrui edition); impact factor 2.2 (journal website); fully open access; APC about USD 2,470; median 90 days to acceptance (96 articles, last 24 months); 214 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Journal of Molecular and Cellular Cardiology Plus is published by Elsevier and is classed under Medicine in the CAS Journal Ranking. By OpenAlex counts of its recent articles, its largest topics are Cardiac Fibrosis and Remodeling, Cardiovascular Function and Risk Factors and Cardiomyopathy and Myosin Studies, together about 36.1% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Molecular and Cellular Cardiology Plus (JMCC PLUS) is a new open access journal of the International Society for Heart Research (ISHR). The journal aims to publish fundamental and translational research that advances knowledge of the mechanisms responsible for both normal and diseased cardiovascular function.At JMCC PLUS we focus on robust scientific validity and high technical quality. In addition to mechanistic research, we also consider rigorously tested negative results, replication studies, studies repeating key experiments in different model systems and datasets generated from functional or multi-omics studies as resource papers. We accept submission of Research Articles, Resource papers, Reviews and Correspondence.Our editorial process is fast and transparent and open access ensures that articles are available to everyone without restrictions.Authors of studies deemed to be of high quality and interest may be offered an opportunity to present their work in a Webinar sponsored by the Society (ISHR). For further information on previous webinars please see our JMCC-ISHR YouTube channel. Our social media team will work hard to promote your work on our social media channels. International Society for Heart Research has been set up in 1968 and our community is made up over 3,000 members, in 7 international Sections (Australasian, Chinese, European, Indian, Japanese, Latin American and North American). By publishing in JMCC PLUS, your work has the opportunity to be showcased at ISHRs World Congress and Section Meetings.
From the journal's Aims & Scope
Research area (LetPub): Dentistry-Dentistry (miscellaneous)
Editor-in-chief Davor PavlovicPublisher website
Editorial board by country: 10 in mainland China (about 17%); most named United States 24, Mainland China 10, United Kingdom 7, Germany 4, Australia 4 (59 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cardiac Fibrosis and RemodelingMedicine16.8%
- Cardiovascular Function and Risk FactorsMedicine10.2%
- Cardiomyopathy and Myosin StudiesMedicine9.1%
- Cardiac electrophysiology and arrhythmiasMedicine8.4%
- Congenital heart defects researchBiochemistry, Genetics and Molecular Biology8.2%
- Mitochondrial Function and PathologyBiochemistry, Genetics and Molecular Biology6.4%
- Cardiac Ischemia and ReperfusionMedicine3.6%
- Atrial Fibrillation Management and OutcomesMedicine2.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cardiac & Cardiovascular Systems | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 2.2Publisher website ·
- CiteScore 2026-06
- 2.1LetPub ·
- CiteScore (publisher)
- 2.1Publisher website ·
- SJR 2026-06
- 0.76LetPub ·
- SNIP 2026-06
- 0.55LetPub ·
- h-index
- 10OpenAlex ·
- i10-index
- 13OpenAlex ·
- 2-year mean citedness
- 0.35OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 66LetPub ·
Articles by year OpenAlex count · 753 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 360 | 360 | 5 |
| 2025 | 214 | 214 | 115 |
| 2024 | 131 | 131 | 124 |
| 2023 | 25 | 25 | 161 |
| 2022 | 23 | 23 | 90 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
90 daysMedian, submission to acceptance · P25–P75 50 days – 130 days
- Acceptance to online
- median 3 days (96 articles)
- Submission to online
- median 93 days
- Sample
- 96 articles with submission and acceptance dates (118 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 6 weeksLetPub ·
- Submission to first decision
- 4 daysPublisher website ·
- First decision after review
- 35 daysPublisher website ·
- Submission to acceptance
- 81 daysPublisher website ·
- Acceptance to publication
- 3 daysPublisher website ·
- Submission to publication (journal-reported)
- about 14 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,470 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 2,020 / EUR 1,890 / GBP 1,620 / JPY 250,540 | — | — | |
| LetPub | USD 1,900 | Yes | — | |
| Publisher website | USD 2,500 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers1, by deadline
Publisher websiteWhat to prepare8 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- ≥ 1
- Manuscript length
- ≤ 6,000 words
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Required
- Highlights
- Optional
- Graphical abstract
- Required
- Cover letter
- Required
Article types accepted9, with length limits
- correspondenceFull Length ArticlesArticles in this category report original research of cardiovascular regulatory mechanisms. To accelerate publication, manuscripts should be…main text ≤ 2,000 words · references ≤ 10
- full length articlesArticles in this category report original research of cardiovascular regulatory mechanisms. To accelerate publication, manuscripts should be no longer than appr…Length not stated
- how-to (methods and resources) articlesThis category of papers is designed to highlight emerging experimental methodologies (particularly new and technically challenging methods), new experimental mo…Length not stated
- original paperFull Length ArticlesArticles in this category report original research of cardiovascular regulatory mechanisms. To accelerate publication, manuscripts should be…Length not stated
- original researchFull Length ArticlesArticles in this category report original research of cardiovascular regulatory mechanisms. To accelerate publication, manuscripts should be…Length not stated
- reviewFull Length ArticlesArticles in this category report original research of cardiovascular regulatory mechanisms. To accelerate publication, manuscripts should be…main text ≤ 6,000 words · abstract ≤ 250 words
- review articleFull Length ArticlesArticles in this category report original research of cardiovascular regulatory mechanisms. To accelerate publication, manuscripts should be…main text ≤ 6,000 words
- reviewsReview Articles provide an updated and comprehensive view of a specific area in cardiovascular research. Review Articles should generally be no longer than 6000…Length not stated
- short communicationFull Length ArticlesArticles in this category report original research of cardiovascular regulatory mechanisms. To accelerate publication, manuscripts should be…main text ≤ 2,000 words · abstract ≤ 100 words · figures and tables ≤ 2 · references ≤ 15
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- Data availability Omics Data Sharing
Transcriptome data must be deposited in GEO Model summary
JMCC requires that authors publicly release all 'omics data in a relevant data repository, and include the citation and link for the dataset in your article at the time of submission. If this is not possible, authors must make a statement explaining why research cannot be shared. Genomics, transcriptomics, metabolomics, proteomics, lipidomics, glycomics, or otherwise high throughput data and relat…
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2772-9761
- Society / sponsor
- International Society for Heart Research
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Journal of Molecular and Cellular Cardiology Plus
What CAS zone is Journal of Molecular and Cellular Cardiology Plus in?
In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Molecular and Cellular Cardiology Plus?
The journal's website gives an impact factor of 2.2; this is the journal's own figure, as LetPub lists none for it; CiteScore 2.1, h-index 10.
How long does peer review take at Journal of Molecular and Cellular Cardiology Plus?
Based on the dates recorded on 96 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 90 days (interquartile range 50–130 days); authors report an average review time of about 6 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Molecular and Cellular Cardiology Plus?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: ≥ 1; Manuscript length: ≤ 6,000 words; Reference style: Numbered, in order of citation; Suggested reviewers: Required; Highlights: Optional; Graphical abstract: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Molecular and Cellular Cardiology Plus based?
Of the 59 board members whose country the journal's board page names, 10 (about 17%) are in mainland China; the countries named most often are United States (24), Mainland China (10) and United Kingdom (7). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Molecular and Cellular Cardiology Plus?
According to LetPub and DOAJ records, Journal of Molecular and Cellular Cardiology Plus is indexed in ESCI, Scopus and DOAJ.
Is Journal of Molecular and Cellular Cardiology Plus open access, and what is the APC?
Journal of Molecular and Cellular Cardiology Plus is a fully open-access journal. APC about USD 2,470.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .